Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long term results of liver transplantation for Wilson's disease: experience in France.
Guillaud O, Dumortier J, Sobesky R, Debray D, Wolf P, Vanlemmens C, Durand F, Calmus Y, Duvoux C, Dharancy S, Kamar N, Boudjema K, Bernard PH, Pageaux GP, Salamé E, Gugenheim J, Lachaux A, Habes D, Radenne S, Hardwigsen J, Chazouillères O, Trocello JM, Woimant F, Ichai P, Branchereau S, Soubrane O, Castaing D, Jacquemin E, Samuel D, Duclos-Vallée JC. Guillaud O, et al. Among authors: calmus y. J Hepatol. 2014 Mar;60(3):579-89. doi: 10.1016/j.jhep.2013.10.025. Epub 2013 Nov 6. J Hepatol. 2014. PMID: 24211743
Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin.
Calmus Y, Duvoux C, Pageaux G, Wolf P, Rostaing L, Vanlemmens C, Botta-Fridlund D, Dharancy S, Gugenheim J, Durand F, Néau-Cransac M, Boillot O, Chazouillères O, Samelson L, Boudjema K, Samuel D. Calmus Y, et al. J Hepatol. 2012 Sep;57(3):564-71. doi: 10.1016/j.jhep.2012.04.022. Epub 2012 May 18. J Hepatol. 2012. PMID: 22613001 Clinical Trial.
Severe fibrosis in patients with recurrent hepatitis C after liver transplantation: a French experience on 250 patients over 15 years (the Orfèvre study).
Dumortier J, Salamé E, Roche B, Hurtova M, Conti F, Radenne S, Vanlemmens C, Pageaux GP, Saliba F, Samuel D, Compagnon P, Neau-Cransac M, Calmus Y, Guillaud O, Gugenheim J, Altieri M, Durand F, Hardwigsen J, Lorho R, Dharancy S, Leroy V, Di Giambattista F, Duvoux C. Dumortier J, et al. Among authors: calmus y. Clin Res Hepatol Gastroenterol. 2014 Jun;38(3):292-9. doi: 10.1016/j.clinre.2014.02.007. Epub 2014 Mar 29. Clin Res Hepatol Gastroenterol. 2014. PMID: 24685602
Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence.
Bosch A, Dumortier J, Maucort-Boulch D, Scoazec JY, Wendum D, Conti F, Morard I, Rubbia-Brandt L, Terris B, Radenne S, Abenavoli L, Poupon R, Chazouillères O, Calmus Y, Boillot O, Giostra E, Corpechot C. Bosch A, et al. Among authors: calmus y. J Hepatol. 2015 Dec;63(6):1449-58. doi: 10.1016/j.jhep.2015.07.038. Epub 2015 Aug 14. J Hepatol. 2015. PMID: 26282232
Use of everolimus in liver transplantation: The French experience.
Dumortier J, Dharancy S, Calmus Y, Duvoux C, Durand F, Salamé E, Saliba F. Dumortier J, et al. Among authors: calmus y. Transplant Rev (Orlando). 2016 Jul;30(3):161-70. doi: 10.1016/j.trre.2015.12.003. Epub 2016 Mar 18. Transplant Rev (Orlando). 2016. PMID: 27083870 Review.
Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
Savale L, Sattler C, Coilly A, Conti F, Renard S, Francoz C, Bouvaist H, Feray C, Borentain P, Jaïs X, Montani D, Parent F, O'Connell C, Hervé P, Humbert M, Simonneau G, Samuel D, Calmus Y, Duvoux C, Durand F, Duclos-Vallée JC, Sitbon O. Savale L, et al. Among authors: calmus y. Hepatology. 2017 May;65(5):1683-1692. doi: 10.1002/hep.28990. Epub 2017 Mar 14. Hepatology. 2017. PMID: 27997987
Early Switch From Tacrolimus to Everolimus After Liver Transplantation: Outcomes at 2 Years.
Saliba F, Duvoux C, Dharancy S, Dumortier J, Calmus Y, Gugenheim J, Kamar N, Salamé E, Neau-Cransac M, Vanlemmens C, Durand F, Pageaux G, Leroy V, Hardwigsen J, Gharbi H, Masson C, Tindel M, Conti F. Saliba F, et al. Among authors: calmus y. Liver Transpl. 2019 Dec;25(12):1822-1832. doi: 10.1002/lt.25664. Liver Transpl. 2019. PMID: 31631501 Free PMC article.
Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.
Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Boudjema K, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouilleres O, Dhumeaux D, Cherqui D, Duvoux C. Decaens T, et al. Among authors: calmus y. Liver Transpl. 2005 Jul;11(7):767-775. doi: 10.1002/lt.20418. Liver Transpl. 2005. PMID: 15973710 Free article.
254 results